Delivery Order 36F79726D0092-36C25226N0475
Award Date 7/2/26
Potential Completion Date 7/1/27
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
9014 St Gallen, Switzerland
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $11,310.02 firm-fixed-price delivery order contract awarded by the U.S. Department of Veterans Affairs (VA) to Vifor (International) AG, a Swiss-based pharmaceutical manufacturer. The contract is for the delivery of KORSUVA, a medication used to treat pruritus. This contract was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is not set aside for any specific business category. Vifor (International) AG also holds two significant Blanket Purchase...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) awarded a $2,425.46 firm-fixed-price delivery order to Vifor (International) AG, a foreign-owned for-profit pharmaceutical manufacturer, to provide the emergency medication KORSUVA (difelikefalin) to VHA's Veterans Integrated Service Network 21. This delivery order was placed against Vifor's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). The order has a performance period through May...
- Vifor (International) AG was awarded a $3,638.19 delivery order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 to supply pharmaceuticals under the Pharmaceuticals and Drugs Federal Supply Schedule. The order has a completion date of April 30, 2024 and was awarded on January 31, 2024 without a set-aside designation. Vifor will provide KORSUVA, a pharmaceutical used to treat medical conditions, to VA facilities located in La Vergne,...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $1,212.73 firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company, to supply DIFELIKEFALIN 50MCG/ML INJ,SOLN VIAL,1.3ML (KORSUVA) pharmaceuticals to VA facilities in Redwood City, CA. This order was placed under the VA's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract. Vifor has also received previous awards from the VA, including a $23.8 million Blanket...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm-fixed price delivery order to Vifor (International) AG, a global biotechnology company, to supply the medication KRYSTEXXA 8MG. The $3,678.19 order is placed against Vifor's Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) contract, which allows the VA to streamline acquisition of critical pharmaceuticals to support healthcare for veterans. No set-aside was used for this delivery order. Vifor...
- This federal contract award is for the delivery of the pharmaceutical product KRYSTEXXA 8MG to the Department of Veterans Affairs (VA) Veterans Health Administration. The $2,425.46 firm-fixed price delivery order was awarded to the prime contractor Vifor (International) AG, a global biotechnology company that provides pharmaceuticals and drugs through its Federal Supply Schedule contract. The contract is associated with the VA's Pharmaceuticals and Drugs (FSS-61-IB) Schedule, and the delivery...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a $10,102.19 delivery order to Otsuka America Pharmaceutical Inc. on June 8, 2020, for Tolvaptan, a specialty pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia. This firm-fixed-price delivery order, which was completed by June 30, 2020, was issued without any set-aside designation and is to be performed in Pittsburgh, Pennsylvania. The contract was executed under...
- Veterans Integrated Service Network 5 issued a $2,016.52 delivery order to Ardelyx, Inc. on December 31, 2025, for XPHOZAH 30 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside designation. Place of performance is Dublin, OH. The ultimate completion date is January 2, 2026. The Federal Supply Schedule provides the parent vehicle framework for VA medical centers nationwide to procure specialized medications for veterans with...
- This delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) was awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 to Horizon Therapeutics USA Inc. for the provision of pegolticase, a drug used to treat gout, with a potential value of $16,558.72. The order has a firm fixed price and period of performance through March 31, 2022 to support the VA's healthcare programs serving veterans in the Lake...
- The Department of Veterans Affairs Veterans Integrated Service Network 21 awarded a $12,580.72 firm fixed-price delivery order to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan) on August 5, 2024, with an ultimate completion date of August 19, 2024. This delivery order was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and does not utilize a set-aside designation. The place of performance is Potomac, Maryland. Jynarque is a specialty pharmaceutical...